Keyphrases
Acute Myeloid Leukemia
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Anthracycline-induced Cardiotoxicity
100%
Anthracyclines
25%
Cardiac Function
25%
Cardiotoxicity
25%
Clinical Records
25%
Daunorubicin
25%
Diastolic Dysfunction
25%
Diastolic Function
25%
Echocardiography
25%
Ejection Fraction
25%
Equivalent Dose
25%
Hematopoietic Stem Cell Transplantation
50%
Idarubicin
25%
Improved Survival
50%
Induction Therapy
25%
Leukemia Patients
100%
Overall Survival
25%
Paucity
25%
Survival Outcomes
50%
Systolic Dysfunction
25%
Systolic Function
25%
Transient Reduction
25%
Transplant Outcomes
25%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Anthracycline
100%
Cardiotoxicity
100%
Diastolic Dysfunction
25%
Diastolic Function
25%
Echocardiography
25%
Ejection Fraction
25%
Equivalent Dose
25%
Heart Function
25%
Hematopoietic Stem Cell Transplantation
50%
Idarubicin
25%
Liposomal Daunorubicin
25%
Overall Survival
25%
Systolic Dysfunction
25%
Systolic Function
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Anthracycline
100%
Cardiotoxicity
100%
Daunorubicin
25%
Diastolic Dysfunction
25%
Idarubicin
25%
Overall Survival
25%
Systolic Dysfunction
25%